WEDNESDAY, Jan. 5, 2022 (HealthDay News) — The U.S. Centers for Disease Control and Prevention on Wednesday endorsed the emergency use of Pfizer’s booster shots for children ages 12 to 17, expanding protection to adolescents and teens as students return to classes and the highly contagious Omicron variant surges acrossContinue Reading

WEDNESDAY, Jan. 5, 2022 (HealthDay News) — Feeding eggs to infants could reduce their risk of egg allergy later on, new research suggests. For the study, researchers at the University at Buffalo in New York, analyzed U.S. government data from more than 2,200 parents who were surveyed about their children’sContinue Reading

TUESDAY, Jan. 4, 2022 (HealthDay News) — Can eating a highly restrictive “few-foods diet” ease the classic symptoms of attention deficit hyperactivity disorder (ADHD) in kids? New research suggests that short-term nutritional intervention, which tests whether certain foods are a trigger for ADHD symptoms through the process of elimination, mightContinue Reading

TUESDAY, Jan. 4, 2022 (HealthDay News) — COVID-19 hospitalizations among children are surging across the United States just as students return to school and the highly transmissible Omicron variant begins to dominate the country. At least nine states have reported record numbers of COVID-related pediatric hospitalizations: They include Connecticut, Georgia,Continue Reading

TUESDAY, Jan. 4, 2022 (HealthDay News) – Young patients with early-onset scoliosis, a dangerous curvature of the spine, have two options for surgery, but a new study finds one of the procedures results in fewer complications. For 8- to 11-year-olds, growth-friendly surgery that allows the spine to continue growing mightContinue Reading

MONDAY, Jan. 3, 2022 (HealthDay News) — Many parents struggle with the decision to let their kids play tackle football or other contact sports due to the risk of concussions and long-term brain diseases that may occur with repeated head blows. Now, new research suggests that head trauma and concussionsContinue Reading

MONDAY, Jan. 3, 2022 (HealthDay News) — An international trial found that a once-a-day antiretroviral medication for kids with HIV is not only cheap and easy to take, but also better at suppressing HIV than standard treatments. “Our findings provide strong evidence for the global rollout of dolutegravir for childrenContinue Reading